Tokyo - Delayed Quote JPY
Mochida Pharmaceutical Co., Ltd. (4534.T)
2,976.00
+54.00
+(1.85%)
At close: May 23 at 3:30:00 PM GMT+9
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
104,505,000
102,885,000
103,261,000
110,179,000
102,995,000
Cost of Revenue
52,665,000
50,815,000
48,146,000
50,626,000
48,203,000
Gross Profit
51,840,000
52,070,000
55,114,000
59,553,000
54,791,000
Operating Expense
46,196,000
46,267,000
46,607,000
45,161,000
42,788,000
Operating Income
5,644,000
5,803,000
8,507,000
14,392,000
12,003,000
Net Non Operating Interest Income Expense
2,000
0
2,000
2,000
3,000
Pretax Income
6,179,000
6,160,000
9,044,000
14,591,000
11,900,000
Tax Provision
1,645,000
1,613,000
2,395,000
4,022,000
3,312,000
Net Income Common Stockholders
4,534,000
4,547,000
6,649,000
10,569,000
8,587,000
Diluted NI Available to Com Stockholders
4,534,000
4,547,000
6,649,000
10,569,000
8,587,000
Basic EPS
128.12
126.80
178.93
277.39
222.29
Diluted EPS
128.12
126.80
178.93
277.39
222.29
Basic Average Shares
35,483.68
35,859.62
37,160.99
38,102
38,633
Diluted Average Shares
35,483.68
35,859.62
37,160.99
38,102
38,633
Total Operating Income as Reported
5,643,000
5,802,000
8,507,000
14,392,000
12,003,000
Total Expenses
98,861,000
97,082,000
94,753,000
95,787,000
90,991,000
Net Income from Continuing & Discontinued Operation
4,534,000
4,547,000
6,649,000
10,569,000
8,587,000
Normalized Income
4,448,148.24
4,456,226
6,679,870
10,713,076
8,846,920
Interest Income
5,000
2,000
2,000
2,000
3,000
Interest Expense
3,000
2,000
0
0
--
Net Interest Income
2,000
0
2,000
2,000
3,000
EBIT
6,182,000
6,162,000
9,044,000
14,591,000
12,003,000
EBITDA
9,078,000
8,970,000
11,716,000
17,280,000
14,745,000
Reconciled Cost of Revenue
52,665,000
50,815,000
48,146,000
50,626,000
48,203,000
Reconciled Depreciation
2,896,000
2,808,000
2,672,000
2,689,000
2,742,000
Net Income from Continuing Operation Net Minority Interest
4,534,000
4,547,000
6,649,000
10,569,000
8,587,000
Total Unusual Items Excluding Goodwill
117,000
123,000
-42,000
-199,000
-360,000
Total Unusual Items
117,000
123,000
-42,000
-199,000
-360,000
Normalized EBITDA
8,961,000
8,847,000
11,758,000
17,479,000
15,105,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
31,148.24
32,226
-11,130
-54,924
-100,080
3/31/2021 - 1/1/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade